Literature DB >> 10397373

The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors.

D Belelli1, M Pistis, J A Peters, J J Lambert.   

Abstract

The positive allosteric effects of four structurally distinct general anaesthetics (propofol, pentobarbitone, etomidate and 5alpha-pregnan-3alpha-ol-20-one [5alpha3alpha]) upon recombinant GABA(A) (alpha6beta3gamma2L), invertebrate GABA (RDL) and glycine (alpha1) receptors expressed in Xenopus laevis oocytes have been determined. Propofol and pentobarbitone enhanced agonist (GABA or glycine as appropriate) evoked currents at GABA(A), glycine, and RDL receptors, whereas etomidate and 5alpha3alpha were highly selective for the GABA(A) receptor. Utilizing site-directed mutagenesis, we demonstrate that the nature of the interaction of propofol, pentobarbitone and etomidate (but not 5alpha3alpha) with mammalian and invertebrate ionotropic GABA receptors depends critically upon the nature of a single amino acid located in the second transmembrane region (TM2) of these receptors. These data are discussed in relation to the specificity of action of general anaesthetics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397373     DOI: 10.1016/s0197-0186(99)00037-6

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  19 in total

1.  Cannabinoids throw up a conundrum.

Authors:  DeWayne Townsend; Stanley A Thayer; David R Brown
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Identification of a fluorescent general anesthetic, 1-aminoanthracene.

Authors:  Christopher A Butts; Jin Xi; Grace Brannigan; Abdalla A Saad; Srinivasan P Venkatachalan; Robert A Pearce; Michael L Klein; Roderic G Eckenhoff; Ivan J Dmochowski
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

3.  General anesthesia alters time perception by phase shifting the circadian clock.

Authors:  James F Cheeseman; Eva C Winnebeck; Craig D Millar; Lisa S Kirkland; James Sleigh; Mark Goodwin; Matt D M Pawley; Guy Bloch; Konstantin Lehmann; Randolf Menzel; Guy R Warman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

4.  Flavan-3-ol esters: new agents for exploring modulatory sites on GABA(A) receptors.

Authors:  Sebastian P Fernandez; Nasiara Karim; Kenneth N Mewett; Mary Chebib; Graham Ar Johnston; Jane R Hanrahan
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Tolerance to allopregnanolone with focus on the GABA-A receptor.

Authors:  Sahruh Turkmen; Torbjorn Backstrom; Goran Wahlstrom; Lotta Andreen; Inga-Maj Johansson
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro.

Authors:  Leanne Coyne; George Lees; Russell A Nicholson; Jian Zheng; Katherine D Neufield
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans.

Authors:  Bruce A Bamber; Roy E Twyman; Erik M Jorgensen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Kinetic analysis of voltage-dependent potentiation and block of the glycine alpha 3 receptor by a neuroactive steroid analogue.

Authors:  Xiaochun Jin; Douglas F Covey; Joe Henry Steinbach
Journal:  J Physiol       Date:  2009-01-05       Impact factor: 5.182

9.  Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors.

Authors:  Marcello Usala; Sally Anne Thompson; Paul J Whiting; Keith A Wafford
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 10.  Mechanisms of neurosteroid interactions with GABA(A) receptors.

Authors:  Gustav Akk; Douglas F Covey; Alex S Evers; Joe Henry Steinbach; Charles F Zorumski; Steven Mennerick
Journal:  Pharmacol Ther       Date:  2007-04-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.